Literature DB >> 26405567

Phenotypic analysis of T cells infiltrating colon cancers: Correlations with oncogenetic status.

Mircea Chirica1, Lionel Le Bourhis2, Jacqueline Lehmann-Che3, Victor Chardiny2, Fatiha Bouhidel4, Laure Foulboeuf2, Jean Marc Gornet5, Nelson Lourenco5, Nicolas Dulphy2, Antoine Toubert2, Matthieu Allez6.   

Abstract

Colorectal cancers (CRC) develop in the face of an important immune system associated with the intestinal mucosal tissue. The immune response against the tumor has been proposed to affect the prognosis of patients undergoing treatment for CRC. In this study T cells infiltrating the tumor were compared with T cells populating the unaffected neighboring mucosal tissue and cells from the peripheral blood. We observed that T cells from the tumor harbor an activated phenotype, with engagement of the NKG2D pathway in CD8 T cells. We show that mucosal and tumor-infiltrating T cells are enriched in NKG2D CD4 T cells, which exhibit cytotoxic functions. Finally, T cell populations in the tumor were modified according to its oncogenetic status, with higher percentages of CD8 T cells isolated from patients with microsatellite instable tumor status.

Entities:  

Keywords:  Colon cancer; NKG2D; T cells; microsatellite instability

Year:  2015        PMID: 26405567      PMCID: PMC4570110          DOI: 10.1080/2162402X.2015.1016698

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  32 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Effector memory T cells, early metastasis, and survival in colorectal cancer.

Authors:  Franck Pagès; Anne Berger; Matthieu Camus; Fatima Sanchez-Cabo; Anne Costes; Robert Molidor; Bernhard Mlecnik; Amos Kirilovsky; Malin Nilsson; Diane Damotte; Tchao Meatchi; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Jérôme Galon
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

Review 3.  Development and progression of colorectal neoplasia.

Authors:  Upender Manne; Chandrakumar Shanmugam; Venkat R Katkoori; Harvey L Bumpers; William E Grizzle
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 4.  The chromosomal instability pathway in colon cancer.

Authors:  Maria S Pino; Daniel C Chung
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

5.  Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

Authors:  Bernhard Mlecnik; Marie Tosolini; Amos Kirilovsky; Anne Berger; Gabriela Bindea; Tchao Meatchi; Patrick Bruneval; Zlatko Trajanoski; Wolf-Herman Fridman; Franck Pagès; Jérôme Galon
Journal:  J Clin Oncol       Date:  2011-01-18       Impact factor: 44.544

Review 6.  Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression?

Authors:  Theresa L Whiteside
Journal:  Cancer Immunol Immunother       Date:  2013-11-10       Impact factor: 6.968

7.  NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity.

Authors:  Cristina Maccalli; Daniela Pende; Chiara Castelli; Maria Cristina Mingari; Paul F Robbins; Giorgio Parmiani
Journal:  Eur J Immunol       Date:  2003-07       Impact factor: 5.532

Review 8.  [Immune response and colorectal cancer].

Authors:  David Tougeron; Emilie Fauquembergue; Jean-Baptiste Latouche
Journal:  Bull Cancer       Date:  2013-03       Impact factor: 1.276

9.  A simple p53 functional assay for screening cell lines, blood, and tumors.

Authors:  J M Flaman; T Frebourg; V Moreau; F Charbonnier; C Martin; P Chappuis; A P Sappino; I M Limacher; L Bron; J Benhattar
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

Review 10.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

View more
  8 in total

1.  Alterations of circulating lymphocyte subsets in patients with colorectal carcinoma.

Authors:  Johanna Waidhauser; Pia Nerlinger; Tim Tobias Arndt; Stefan Schiele; Florian Sommer; Sebastian Wolf; Phillip Löhr; Stefan Eser; Gernot Müller; Rainer Claus; Bruno Märkl; Andreas Rank
Journal:  Cancer Immunol Immunother       Date:  2021-12-20       Impact factor: 6.630

2.  Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.

Authors:  Juan Fang; Xiaoxu Li; Da Ma; Xiangqi Liu; Yichen Chen; Yun Wang; Vivian Wai Yan Lui; Juan Xia; Bin Cheng; Zhi Wang
Journal:  BMC Cancer       Date:  2017-05-26       Impact factor: 4.430

3.  NK1.1- CD4+ NKG2D+ T cells suppress DSS-induced colitis in mice through production of TGF-β.

Authors:  Xingxing Qian; Chunxia Hu; Sen Han; Zhijie Lin; Weiming Xiao; Yanbing Ding; Yu Zhang; Li Qian; Xiaoqing Jia; Guoqiang Zhu; Weijuan Gong
Journal:  J Cell Mol Med       Date:  2017-02-22       Impact factor: 5.310

4.  Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment.

Authors:  Tristan Courau; Julie Bonnereau; Justine Chicoteau; Hugo Bottois; Romain Remark; Laura Assante Miranda; Antoine Toubert; Mathieu Blery; Thomas Aparicio; Matthieu Allez; Lionel Le Bourhis
Journal:  J Immunother Cancer       Date:  2019-03-14       Impact factor: 13.751

Review 5.  G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis.

Authors:  Damian Jacenik; Ellen J Beswick; Wanda M Krajewska; Eric R Prossnitz
Journal:  World J Gastroenterol       Date:  2019-08-14       Impact factor: 5.742

6.  Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data.

Authors:  Zheqi Liu; Wenkai Zhou; Chengzhong Lin; Xiaoning Wang; Xu Zhang; Yu Zhang; Rong Yang; Wantao Chen; Wei Cao
Journal:  Aging (Albany NY)       Date:  2020-12-09       Impact factor: 5.682

7.  CBX3 is a Prognostic Biomarker Correlated with ATR Activation and Immune Infiltration in Head and Neck Squamous Cell Carcinoma.

Authors:  Xu Zhang; Wenkai Zhou; Yu Zhang; Zheqi Liu
Journal:  Int J Gen Med       Date:  2022-02-15

8.  A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals.

Authors:  Philippos Demetriou; Enas Abu-Shah; Salvatore Valvo; Sarah McCuaig; Viveka Mayya; Audun Kvalvaag; Thomas Starkey; Kseniya Korobchevskaya; Lennard Y W Lee; Matthias Friedrich; Elizabeth Mann; Mikhail A Kutuzov; Matteo Morotti; Nina Wietek; Heather Rada; Shamsideen Yusuf; Jehan Afrose; Anastasios Siokis; Michael Meyer-Hermann; Ahmed Ashour Ahmed; David Depoil; Michael L Dustin
Journal:  Nat Immunol       Date:  2020-09-14       Impact factor: 25.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.